Conditions for the Implementation of a Patient Education Program Dedicated to Cancer Patients Treated by Oral Anticancer Therapy.
Patient Prefer Adherence
; 14: 2263-2277, 2020.
Article
em En
| MEDLINE
| ID: mdl-33244223
ABSTRACT
INTRODUCTION:
A patient education program has been developed in the field of cancer for supporting cancer patients undergoing oral anticancer therapies. Its implementation was tested in 3 different settings. The objectives of this study were to 1) identify barriers and facilitators for implementing the patient education program, 2) identify practices encouraging or hindering implementation and 3) produce recommendations for its dissemination.METHODS:
Twenty semi-structured interviews were conducted with caregivers from all three establishments.RESULTS:
The main factors associated with successful implementation were as follows prescribers' representations on patient education, considered of low value; on oral anticancer therapies, considered too dangerous to be handled by the patient him/herself, the indefinite legitimacy of certain professions in charge of patient education programs; patients' engagement in their care pathway and provision of caregivers.CONCLUSION:
Recommendations include developing patient education culture within the environment of the medical doctors' curriculum, to consider contextual, pre-existing cooperative units for implementing patient education, to systematically send patients to patient education programs without practicing triage. Successful implementation of patient education critically depends on the prescribing physicians' perceived value of patient education. Patient education should become mandatory, integrated as part of the cancer care pathway. Physicians lack the necessary time and/or means to assess patients' capacity for engagement, without adequate strategies for their support. Therefore, physicians should systematically refer all patients to patient education, where nurses can tailor their coaching of cancer patients. TRIAL REGISTRATION The study protocol was approved by the IRB SUD EST I (N° EudraCT 2016-A00113-48). All participants were given written and verbal information about the study and gave informed consent to participate.
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Prognostic_studies
/
Qualitative_research
/
Sysrev_observational_studies
Idioma:
En
Revista:
Patient Prefer Adherence
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
França